Clinical Trials Logo

Clinical Trial Summary

Several studies have described the interest of eosinopenia as a marker of infection in internal medicine or in intensive care units. Eosinopenia is an inexpensive and easily accessible biological marker of sepsis. Retrospective work in the adult emergency departments of Strasbourg University Hospitals has shown the good specificity of this biological sign for the diagnosis of infection. Our work aims to confirm the results by a more meaningful study.

Main objective: Evaluation of the interest of eosinopenia in the diagnosis of bacterial infection in ED.

Methodology: inclusion of all patients with criteria for bacterial infection in ED, inclusion of an equivalent number of uninfected control patients.

Duration : 12 months Multicentric prospective study 6 centers : Strasbourg, Hôpital Nord Franche comté, Sélestat, Wissembourg, Colmar, Mulhouse


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03467672
Study type Observational
Source University Hospital, Strasbourg, France
Contact Charles-Eric Dr. LAVOIGNET
Phone 03 84 98 33 97
Email Charles-eric.lavoignet@hnfc.fr
Status Recruiting
Phase
Start date March 23, 2018
Completion date March 2020